Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas

A. Hisatomi, H. Maruyama, L. Orci, Michael Vasko, R. H. Unger

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Alpha adrenergic blockade with phentolamine (10 μM) reduces the glucagon response to severe glucopenia (from 150 to 25 mg/dl) to 22% of the control values in the isolated perfused rat pancreas. Propranolol (10 μM) had no significant effect. Neither alpha nor beta adrenergic blockade reduced the magnitude of glucopenic suppression of insulin secretion, but phentolamine increased insulin levels before and during glucopenia. The pattern of somatostatin secretion in these experiments resembled that of insulin. Depletion of norepinephrine from sympathetic nerve endings by pretreatment with 6-hydroxydopamine lowered the pancreatic norepinephrine content to less than 20% of control values and reduced the glucagon response to glucopenia to 69% of the controls. Combined alpha and beta adrenergic blockade during less severe glucopenia (from 120 to 60 mg/dl) reduced the glucagon response to 21% of controls. However, slight glucopenia (from 100 to 80 mg/dl), which elicited only 11% increase in glucagon in the control experiments, was not altered significantly by combined alpha and beta adrenergic blockade. Morphologic studies of adrenergic nerve terminals labeled with [3H]norepinephrine revealed associations with alpha cells. It is concluded that in the isolated rat pancreas adrenergic mediation accounts for most of the glucagon but not insulin response to glucopenia. It is controlled within the pancreas itself, possibly through a direct enhancement by glucopenia of norepinephrine release from nerve endings.

Original languageEnglish
Pages (from-to)420-426
Number of pages7
JournalJournal of Clinical Investigation
Volume75
Issue number2
StatePublished - 1985
Externally publishedYes

Fingerprint

Glucagon
Adrenergic Agents
Pancreas
Norepinephrine
Insulin
Nerve Endings
Phentolamine
Oxidopamine
Somatostatin
Propranolol

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas. / Hisatomi, A.; Maruyama, H.; Orci, L.; Vasko, Michael; Unger, R. H.

In: Journal of Clinical Investigation, Vol. 75, No. 2, 1985, p. 420-426.

Research output: Contribution to journalArticle

@article{73d241e5dfc54359941c3c1d5c9946cd,
title = "Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas",
abstract = "Alpha adrenergic blockade with phentolamine (10 μM) reduces the glucagon response to severe glucopenia (from 150 to 25 mg/dl) to 22{\%} of the control values in the isolated perfused rat pancreas. Propranolol (10 μM) had no significant effect. Neither alpha nor beta adrenergic blockade reduced the magnitude of glucopenic suppression of insulin secretion, but phentolamine increased insulin levels before and during glucopenia. The pattern of somatostatin secretion in these experiments resembled that of insulin. Depletion of norepinephrine from sympathetic nerve endings by pretreatment with 6-hydroxydopamine lowered the pancreatic norepinephrine content to less than 20{\%} of control values and reduced the glucagon response to glucopenia to 69{\%} of the controls. Combined alpha and beta adrenergic blockade during less severe glucopenia (from 120 to 60 mg/dl) reduced the glucagon response to 21{\%} of controls. However, slight glucopenia (from 100 to 80 mg/dl), which elicited only 11{\%} increase in glucagon in the control experiments, was not altered significantly by combined alpha and beta adrenergic blockade. Morphologic studies of adrenergic nerve terminals labeled with [3H]norepinephrine revealed associations with alpha cells. It is concluded that in the isolated rat pancreas adrenergic mediation accounts for most of the glucagon but not insulin response to glucopenia. It is controlled within the pancreas itself, possibly through a direct enhancement by glucopenia of norepinephrine release from nerve endings.",
author = "A. Hisatomi and H. Maruyama and L. Orci and Michael Vasko and Unger, {R. H.}",
year = "1985",
language = "English",
volume = "75",
pages = "420--426",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "2",

}

TY - JOUR

T1 - Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas

AU - Hisatomi, A.

AU - Maruyama, H.

AU - Orci, L.

AU - Vasko, Michael

AU - Unger, R. H.

PY - 1985

Y1 - 1985

N2 - Alpha adrenergic blockade with phentolamine (10 μM) reduces the glucagon response to severe glucopenia (from 150 to 25 mg/dl) to 22% of the control values in the isolated perfused rat pancreas. Propranolol (10 μM) had no significant effect. Neither alpha nor beta adrenergic blockade reduced the magnitude of glucopenic suppression of insulin secretion, but phentolamine increased insulin levels before and during glucopenia. The pattern of somatostatin secretion in these experiments resembled that of insulin. Depletion of norepinephrine from sympathetic nerve endings by pretreatment with 6-hydroxydopamine lowered the pancreatic norepinephrine content to less than 20% of control values and reduced the glucagon response to glucopenia to 69% of the controls. Combined alpha and beta adrenergic blockade during less severe glucopenia (from 120 to 60 mg/dl) reduced the glucagon response to 21% of controls. However, slight glucopenia (from 100 to 80 mg/dl), which elicited only 11% increase in glucagon in the control experiments, was not altered significantly by combined alpha and beta adrenergic blockade. Morphologic studies of adrenergic nerve terminals labeled with [3H]norepinephrine revealed associations with alpha cells. It is concluded that in the isolated rat pancreas adrenergic mediation accounts for most of the glucagon but not insulin response to glucopenia. It is controlled within the pancreas itself, possibly through a direct enhancement by glucopenia of norepinephrine release from nerve endings.

AB - Alpha adrenergic blockade with phentolamine (10 μM) reduces the glucagon response to severe glucopenia (from 150 to 25 mg/dl) to 22% of the control values in the isolated perfused rat pancreas. Propranolol (10 μM) had no significant effect. Neither alpha nor beta adrenergic blockade reduced the magnitude of glucopenic suppression of insulin secretion, but phentolamine increased insulin levels before and during glucopenia. The pattern of somatostatin secretion in these experiments resembled that of insulin. Depletion of norepinephrine from sympathetic nerve endings by pretreatment with 6-hydroxydopamine lowered the pancreatic norepinephrine content to less than 20% of control values and reduced the glucagon response to glucopenia to 69% of the controls. Combined alpha and beta adrenergic blockade during less severe glucopenia (from 120 to 60 mg/dl) reduced the glucagon response to 21% of controls. However, slight glucopenia (from 100 to 80 mg/dl), which elicited only 11% increase in glucagon in the control experiments, was not altered significantly by combined alpha and beta adrenergic blockade. Morphologic studies of adrenergic nerve terminals labeled with [3H]norepinephrine revealed associations with alpha cells. It is concluded that in the isolated rat pancreas adrenergic mediation accounts for most of the glucagon but not insulin response to glucopenia. It is controlled within the pancreas itself, possibly through a direct enhancement by glucopenia of norepinephrine release from nerve endings.

UR - http://www.scopus.com/inward/record.url?scp=0021996298&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021996298&partnerID=8YFLogxK

M3 - Article

C2 - 2857731

AN - SCOPUS:0021996298

VL - 75

SP - 420

EP - 426

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 2

ER -